SV Health Investors is a healthcare and life sciences venture capital and growth equity firm with over 30 years of experience in the US and UK. They manage specialized and diversified healthcare funds spanning all sectors and stages, focusing on biotechnology (including dementia), healthcare growth equity, and medtech. The firm has invested in over 175 companies, leading to 75 IPOs and M&As, and has historical commitments totaling $4.0 billion. Their team comprises over 50 investment professionals and operating partners based in Boston and London.
Is SV Health Investors the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with SV Health Investors, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Seed, Series A, Series B or later
First ticket size
US$5,000,000 - US$400,000,000
When reaching out to SV Health Investors, founders should highlight differentiated science or technology with clear clinical and commercial potential, as well as a credible path to regulatory milestones. Demonstrating a strong, experienced management team and a well-articulated plan for capital efficiency will resonate, especially if you can show how your solution addresses significant unmet needs in healthcare. Be prepared to discuss your strategy for navigating complex healthcare markets and reimbursement landscapes, as SV Health Investors values operational rigor and market insight.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.